{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T19:45:18Z","timestamp":1770147918142,"version":"3.49.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T00:00:00Z","timestamp":1686700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T00:00:00Z","timestamp":1686700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1038\/s41591-023-02378-5","type":"journal-article","created":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T16:01:27Z","timestamp":1686758487000},"page":"2167-2170","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Psychedelic treatments for mental health conditions pose challenges for informed consent"],"prefix":"10.1038","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4028-5648","authenticated-orcid":false,"given":"Carolina","family":"Seybert","sequence":"first","affiliation":[]},{"given":"Gon\u00e7alo","family":"Cotovio","sequence":"additional","affiliation":[]},{"given":"Lu\u00eds","family":"Madeira","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8190-9587","authenticated-orcid":false,"given":"Miguel","family":"Ricou","sequence":"additional","affiliation":[]},{"given":"Ana Matos","family":"Pires","sequence":"additional","affiliation":[]},{"given":"Albino J.","family":"Oliveira-Maia","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2023,6,14]]},"reference":[{"key":"2378_CR1","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1056\/NEJMoa2206443","volume":"387","author":"GM Goodwin","year":"2022","unstructured":"Goodwin, G. M. et al. N. Engl. J. Med. 387, 1637\u20131648 (2022).","journal-title":"N. Engl. J. Med."},{"key":"2378_CR2","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1177\/0269881116675513","volume":"30","author":"RR Griffiths","year":"2016","unstructured":"Griffiths, R. R. et al. J. Psychopharmacol. (Oxf.) 30, 1181\u20131197 (2016).","journal-title":"J. Psychopharmacol. (Oxf.)"},{"key":"2378_CR3","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/s41591-021-01336-3","volume":"27","author":"JM Mitchell","year":"2021","unstructured":"Mitchell, J. M. et al. Nat. Med. 27, 1025\u20131033 (2021).","journal-title":"Nat. Med."},{"key":"2378_CR4","doi-asserted-by":"publisher","first-page":"109165","DOI":"10.1016\/j.neuropharm.2022.109165","volume":"216","author":"WR Smith","year":"2022","unstructured":"Smith, W. R. & Appelbaum, P. S. Neuropharmacology 216, 109165 (2022).","journal-title":"Neuropharmacology"},{"key":"2378_CR5","doi-asserted-by":"crossref","unstructured":"Kwan, A. C. et al. Nat. Neurosci. 25, 1407\u20131419 (2022).","DOI":"10.1038\/s41593-022-01177-4"},{"key":"2378_CR6","doi-asserted-by":"crossref","unstructured":"Johnson, M. W. et al. J. Psychopharmacol. (Oxf.) 22, 603\u2013620 (2008).","DOI":"10.1177\/0269881108093587"},{"key":"2378_CR7","doi-asserted-by":"crossref","unstructured":"Cavarra, M. et al. Front. Psychol. 13, 887255 (2022).","DOI":"10.3389\/fpsyg.2022.887255"},{"key":"2378_CR8","doi-asserted-by":"crossref","unstructured":"Moreno, F. A. et al. J. Clin. Psychiatry 67, 1735\u20131740 (2006).","DOI":"10.4088\/JCP.v67n1110"},{"key":"2378_CR9","doi-asserted-by":"publisher","first-page":"735523","DOI":"10.3389\/fpsyt.2021.735523","volume":"12","author":"MJ Spriggs","year":"2021","unstructured":"Spriggs, M. J. et al. Front. Psychiatry 12, 735523 (2021).","journal-title":"Front. Psychiatry"},{"key":"2378_CR10","doi-asserted-by":"crossref","unstructured":"Ko, K. et al. J. Affect. Disord. 322, 194\u2013204 (2023).","DOI":"10.1016\/j.jad.2022.09.168"},{"key":"2378_CR11","doi-asserted-by":"crossref","unstructured":"dos Santos, R. G. et al. Expert Rev. Clin. Pharmacol. 11, 889\u2013902 (2018).","DOI":"10.1080\/17512433.2018.1511424"},{"key":"2378_CR12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00213-021-06027-y","volume":"239","author":"N Schimmel","year":"2022","unstructured":"Schimmel, N. et al. Psychopharmacology (Berl.) 239, 15\u201333 (2022).","journal-title":"Psychopharmacology (Berl.)"},{"key":"2378_CR13","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1159\/000457960","volume":"86","author":"ST Wilkinson","year":"2017","unstructured":"Wilkinson, S. T. et al. Psychother. Psychosom. 86, 162\u2013167 (2017).","journal-title":"Psychother. Psychosom."},{"key":"2378_CR14","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1080\/15622975.2020.1836399","volume":"22","author":"S Kasper","year":"2021","unstructured":"Kasper, S. et al. World J. Biol. Psychiatry 22, 468\u2013482 (2021).","journal-title":"World J. Biol. Psychiatry"},{"key":"2378_CR15","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/00007691-200404000-00009","volume":"26","author":"R de la Torre","year":"2004","unstructured":"de la Torre, R. et al. Ther. Drug Monit. 26, 137\u2013144 (2004).","journal-title":"Ther. Drug Monit."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41591-023-02378-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-023-02378-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-023-02378-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T08:09:36Z","timestamp":1694765376000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41591-023-02378-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,14]]},"references-count":15,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["2378"],"URL":"https:\/\/doi.org\/10.1038\/s41591-023-02378-5","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,14]]},"assertion":[{"value":"14 June 2023","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.S. received payment from the European Monitoring Centre for Drugs and Drug Addiction. A.M.P. received payment or honoraria from Janssen and Lundbeck and participated in advisory boards for Janssen and Angelini. A.J.O.-M. was the national coordinator for Portugal of trials for treatment-resistant depression of psilocybin, sponsored by Compass Pathways, Ltd (EudraCT number 2017-003288-36), and of esketamine, sponsored by Janssen-Cilag, Ltd (EudraCT NUMBER: 2019-002992-33); received payment or honoraria from MSD, Neurolite AG, Janssen and the European Monitoring Centre for Drugs and Drug Addiction; participated in advisory boards for Janssen and Angelini; and is the recipient of a grant from Schuhfried GmBH. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}